Concepts (45)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Chest Syndrome | 1 | 2011 | 9 | 0.390 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 364 | 0.290 |
Why?
|
| Anesthetics, Dissociative | 1 | 2005 | 23 | 0.250 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1238 | 0.240 |
Why?
|
| Orthopedic Surgeons | 1 | 2024 | 14 | 0.230 |
Why?
|
| Humeral Fractures | 1 | 2024 | 23 | 0.230 |
Why?
|
| Radiologists | 1 | 2024 | 178 | 0.200 |
Why?
|
| Observer Variation | 1 | 2024 | 703 | 0.200 |
Why?
|
| Ketamine | 1 | 2005 | 242 | 0.190 |
Why?
|
| Asthma | 1 | 2005 | 894 | 0.140 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1996 | 25 | 0.140 |
Why?
|
| Pre-Eclampsia | 1 | 1996 | 237 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 98 | 0.100 |
Why?
|
| Spirometry | 1 | 2011 | 153 | 0.090 |
Why?
|
| Triage | 1 | 2013 | 256 | 0.090 |
Why?
|
| Hospitalization | 2 | 2013 | 2161 | 0.090 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 194 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 591 | 0.060 |
Why?
|
| Adolescent | 4 | 2024 | 32647 | 0.060 |
Why?
|
| Pediatric Emergency Medicine | 1 | 2024 | 48 | 0.060 |
Why?
|
| Emergency Medicine | 1 | 2005 | 158 | 0.060 |
Why?
|
| Bronchodilator Agents | 1 | 2005 | 225 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2024 | 39736 | 0.050 |
Why?
|
| Child | 3 | 2024 | 30466 | 0.050 |
Why?
|
| Texas | 1 | 2013 | 6430 | 0.050 |
Why?
|
| Incidence | 1 | 2011 | 5806 | 0.050 |
Why?
|
| Radiography | 1 | 2024 | 1984 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2005 | 2586 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2013 | 8668 | 0.040 |
Why?
|
| Female | 5 | 2024 | 148486 | 0.040 |
Why?
|
| Male | 4 | 2024 | 127917 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2011 | 9464 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 16987 | 0.040 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1996 | 6 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 1996 | 72 | 0.030 |
Why?
|
| Pediatrics | 1 | 2005 | 1185 | 0.030 |
Why?
|
| Risk Factors | 1 | 2013 | 17824 | 0.030 |
Why?
|
| Humans | 5 | 2024 | 270033 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 6182 | 0.030 |
Why?
|
| Prognosis | 1 | 2011 | 22451 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 15172 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13946 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2005 | 33691 | 0.010 |
Why?
|
| Pregnancy | 1 | 1996 | 8107 | 0.010 |
Why?
|
| Adult | 1 | 1996 | 81689 | 0.010 |
Why?
|